Regulatory Approvals

FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care

By

Regulatory Approvals — FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care  Oncology Nursing News

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 7, 2026.

By

Related Post

Regulatory Approvals

FDA approves new drug for pancreatic cancer. Who’s eligible and how does it work?

Regulatory Approvals

FDA approves Priovant’s Lisraya for dermatomyositis

Regulatory Approvals

FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote

Financial News For All

Mergers & Acquisitions

EverBank to combine with WaFd in $3.9 billion reverse merger

Labor

California state worker union to vote on whether to authorize historic strike

Labor

SEIU 1000, union representing California’s public sector, announces vote to authorize strike

Labor

Trump braces for midterms, crucial union vote as Labor Day shows 75,000 lost manufacturing jobs